🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this open-label, randomized, 2-treatment, 2-period crossover...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-07-30
Trial ID
NCT01647659
Treatments Being Tested
This is an open-label, randomized, single-dose, 2-treatment, 2-period, 2-wa...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-02-05
Trial ID
NCT01725100
Treatments Being Tested
To evaluate the safety and tolerability of sotorasib administered in invest...
Status
Active Not Recruiting
Location
Arizona Oncology Associates Professional Corporation
Start Date
2019-12-17
Trial ID
NCT04185883
This was a Phase II, multicenter, non-randomized, open-label study to asses...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-08-05
Trial ID
NCT01336634
Treatments Being Tested
DETERMINE is an open-label phase II/III trial. It will look at targeted tre...
Status
Recruiting
Location
Belfast City Hospital
Start Date
2023-03-01
Trial ID
NCT05722886
The purpose of this study is to evaluate the effect of trametinib once dail...
Status
Completed
Location
Karmanos Cancer Institute Karmanos Cancer Institute
Start Date
2016-10-20
Trial ID
NCT02705963
Treatments Being Tested
A Phase I, single-center, open-label, single-persiod, combined single dose ...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-06-20
Trial ID
NCT01416337
Treatments Being Tested
This is a dose-escalation, Phase I/II, open-label, three-part study. Part 1...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-04-22
Trial ID
NCT02065063
Treatments Being Tested
This was a four part, phase I/II study aimed to evaluate the safety, tolera...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-12-19
Trial ID
NCT01750918
Treatments Being Tested
This is a Phase IIa, open-label, single-arm, multi-center study to evaluate...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-09-19
Trial ID
NCT01943864
Treatments Being Tested